Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status. Freeman CL, Srinivasan S, Hodkinson B, Deshpande S, et al. Blood 2025;145:3052-3056.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Freeman CL, Srinivasan S, Hodkinson B, Deshpande S, et al. Prognostic biomarkers in MCL: insights from the SHINE trial on the impact of MCL35 score and TP53 mutation status. Blood 2025;145:3052-3056.
PMID: 40101138